Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 117 (CCDC117) is a widely conserved protein located at the mitotic spindle and in the nucleus. It facilitates DNA repair, cell cycle progression (especially G1/S transition), and cell proliferation, primarily by interacting with the cytoplasmic iron-sulfur (CIA) complex and the MMS19 protein. CCDC117 is regulated by the cardiac transcription factor Nkx2-5 and is necessary during heart development, especially for the expansion of progenitor cells in the second heart field. Loss of CCDC117 function delays the cell cycle, reduces DNA synthesis, and increases unresolved DNA damage. Genome-wide association studies have linked CCDC117 to cancer susceptibility, and gene mutations can be associated with some neurological and developmental conditions. There are currently no drugs that target CCDC117, and it is not classified as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 117 (CCDC117).